1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 4.1 Market Overview 4.2 Introduction to Market Drivers and Restraints 4.3 Market Drivers 4.3.1 Rising Demand for Non-Invasive Procedures 4.3.2 Availability to Give Enhanced Pictures to the Medical Practitioners for Diagnosing Complex Diseases 4.4 Market Restraints 4.4.1 High Cost Factor Associated With the Products 4.5 Industry Attractiveness - Porter's Five Force Analysis 4.5.1 Threat of New Entrants 4.5.2 Bargaining Power of Buyers/Consumers 4.5.3 Bargaining Power of Suppliers 4.5.4 Threat of Substitute Products 4.5.5 Intensity of Competitive Rivalry 5 MARKET SEGMENTATION 5.1 By Product 5.1.1 Imaging Systems 5.1.1.1 Optical Imaging Systems 5.1.1.2 Spectral Imaging Systems 5.1.2 Illumination Systems 5.1.3 Lenses 5.1.4 Software 5.2 By Application 5.2.1 Ophthalmology 5.2.2 Dentistry 5.2.3 Dermatology 5.2.4 Cardiology 5.2.5 Neurology 5.2.6 Oncology 5.2.7 Biotechnology and Research 5.2.8 Other Applications 5.3 By End User 5.3.1 Diagnostic Imaging Centre 5.3.2 Hospitals 5.3.3 Research Laboratories 5.3.4 Other End Users 5.4 Geography 5.4.1 North America 5.4.1.1 United States 5.4.1.2 Canada 5.4.2 Europe 5.4.2.1 Germany 5.4.2.2 United Kingdom 5.4.2.3 France 5.4.2.4 Rest of Europe 5.4.3 Asia-Pacific 5.4.3.1 China 5.4.3.2 Japan 5.4.3.3 India 5.4.3.4 Rest of Asia-Pacific 5.4.4 Latin America 5.4.5 Middle East & Africa 6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Abbott Laboratories 6.1.2 Carl Zeiss Meditec AG 6.1.3 Leica Microsystems ( Bioptigen, Inc.) 6.1.4 Topcon Corporation 6.1.5 Canon Inc. 6.1.6 Heidelberg Engineering, Inc. 6.1.7 Headwall Photonics, Inc. 6.1.8 Optovue, Inc. 6.1.9 Perkinelmer, Inc. 6.1.10 Koninklijke Philips N.V. 6.1.11 Agfa-Gevaert N.V. 7 INVESTMENT ANALYSIS. 8 MARKET OPPORTUNITIES AND FUTURE TRENDS